Scott M. Wasserman
Amgen Inc.
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Lipoproteins and Cardiovascular Health
Strong evidence · 2 supporting papers · latest 2017
Computational Drug Discovery Methods
Solid evidence · 1 supporting paper · latest 2017
Hormonal Regulation and Hypertension
Solid evidence · 1 supporting paper · latest 2017
Atherosclerosis and Cardiovascular Diseases
Supporting evidence · 1 supporting paper · latest 2017
Cardiac Imaging and Diagnostics
Supporting evidence · 1 supporting paper · latest 2017
Publications (2)
Cognitive Function in a Randomized Trial of Evolocumab
2017DOIPMID 28813214
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
2017DOIPMID 28304224
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Amgen Inc.
Source: OpenAlex · retrieved 2026-09-29